Literature DB >> 10925060

Assessing cardiovascular autonomic neuropathy in diabetes mellitus: how many tests to use?

O May1, H Arildsen.   

Abstract

The aim was to evaluate the relative importance of an established battery of five function tests used in the assessment of cardiovascular autonomic neuropathy (CAN) in diabetes employing spectral analysis of heart rate variability (HRV) as the reference test. In a population-based sample of 178 diabetic persons and 194 non-diabetic controls, five function tests (E/I ratio, Valsalva, 30:15 ratio, Orthostatic-BP, and sustained Handgrip) and power spectral analysis of a 24-h Holter recording were carried out. The high-frequency power during nighttime (LnHF(NIGHT)) was taken to express the parasympathetic function and the daytime low-frequency power (LnLF(DAY)) to express the sympathetic function. The readings were log transformation when appropriate, age-corrected, and standardized to units of standard deviation. Combinations of the three mainly parasympathetic tests and the two mainly sympathetic tests were computed by averaging the standardized readings. A high value of the mean sum of squares in LnHF(NIGHT) or LnLF(DAY) - explained in regression analysis - was assumed to represent the better test or combination of tests. The three parasympathetic function tests each correlated significantly to LnHF(NIGHT). The E/I ratio had a correlation to LnHF(NIGHT) similar to the combination of the three parasympathetic tests and the combination of all five function tests, whereas Valsalva and 30:15 ratio had a significantly poorer association. Sustained Handgrip-correlated significantly poorer to LnLF(DAY) compared to Orthostatic BP and the combination of the two sympathetic tests explained a significantly smaller part of the variation in LnLF(DAY) and LnHF(NIGHT) than did the combination of all five tests. This study indicates that: (1) no information is gained by adding the sympathetic function tests to the parasympathetic tests, (2) the most informative test is the E/I ratio, (3) and knowledge about the degree of CAN as defined by reduced HRV is not significantly increased when the four other function tests assessed are added to the E/I ratio.

Entities:  

Mesh:

Year:  2000        PMID: 10925060     DOI: 10.1016/s1056-8727(00)00062-3

Source DB:  PubMed          Journal:  J Diabetes Complications        ISSN: 1056-8727            Impact factor:   2.852


  10 in total

1.  Determination of nerve conduction abnormalities in patients with impaired glucose tolerance.

Authors:  Sevki Sahin; Sibel Karsidag; Sunay Ayalp; Ahmet Sengul; Onder Us; Kubilay Karsidag
Journal:  Neurol Sci       Date:  2009-05-15       Impact factor: 3.307

2.  A new method of screening for diabetic neuropathy using laser Doppler and photoplethysmography.

Authors:  Sung Woo Kim; Soo Chan Kim; Ki Chang Nam; Eun Seok Kang; Jae Jung Im; Deok Won Kim
Journal:  Med Biol Eng Comput       Date:  2007-10-10       Impact factor: 2.602

3.  Fusion of heart rate variability and salivary cortisol for stress response identification based on adverse childhood experience.

Authors:  Noor Aimie-Salleh; M B Malarvili; Anna C Whittaker
Journal:  Med Biol Eng Comput       Date:  2019-02-07       Impact factor: 2.602

4.  Right-left correlation of the sympathetically induced fluctuations of photoplethysmographic signal in diabetic and non-diabetic subjects.

Authors:  A Buchs; Y Slovik; M Rapoport; C Rosenfeld; B Khanokh; M Nitzan
Journal:  Med Biol Eng Comput       Date:  2005-03       Impact factor: 2.602

5.  Decreased heart rate variability may predict the progression of carotid atherosclerosis in type 2 diabetes.

Authors:  Anders Gottsäter; Asa Rydén Ahlgren; Soumia Taimour; Göran Sundkvist
Journal:  Clin Auton Res       Date:  2006-05-12       Impact factor: 5.625

6.  The prevalence of cardiovascular autonomic neuropathy and its influence on post induction hemodynamic variables in patients with and without diabetes; A prospective cohort study.

Authors:  Jorinde A W Polderman; Nicolaas H Sperna Weiland; Michel H Klaver; Judy Biginski; Marijn Horninge; Markus W Hollmann; J Hans DeVries; Rogier V Immink; Benedikt Preckel; Jeroen Hermanides
Journal:  PLoS One       Date:  2018-11-26       Impact factor: 3.240

Review 7.  Update on the Impact, Diagnosis and Management of Cardiovascular Autonomic Neuropathy in Diabetes: What Is Defined, What Is New, and What Is Unmet.

Authors:  Vincenza Spallone
Journal:  Diabetes Metab J       Date:  2019-02       Impact factor: 5.376

8.  Prevalence and Diagnosis of Diabetic Cardiovascular Autonomic Neuropathy in Beijing, China: A Retrospective Multicenter Clinical Study.

Authors:  Qi Pan; Quanmin Li; Wei Deng; Dong Zhao; Lin Qi; Wei Huang; Li Ma; Hongmei Li; Yufeng Li; Xiaofeng Lyu; Aihong Wang; Hebin Yao; Lixin Guo; Xiaoyan Xing
Journal:  Front Neurosci       Date:  2019-10-25       Impact factor: 4.677

9.  Identifying diabetic patients with cardiac autonomic neuropathy by heart rate complexity analysis.

Authors:  Ahsan H Khandoker; Herbert F Jelinek; Marimuthu Palaniswami
Journal:  Biomed Eng Online       Date:  2009-01-29       Impact factor: 2.819

10.  Small fiber neuropathy associated with hyperlipidemia: utility of cutaneous silent periods and autonomic tests.

Authors:  G Morkavuk; A Leventoglu
Journal:  ISRN Neurol       Date:  2014-03-19
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.